Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study.

Mayu Shiomi Ryu WatanabeShogo MatsudaTakuya KotaniAyana OkazakiYuichi MasudaTsuneyasu YoshidaMikihito ShojiRyosuke TsugeKeiichiro Kadoba Ryosuke HiwaWataru YamamotoAkitoshi TakedaYoshiaki ItohMotomu Hashimoto

Published in: Modern rheumatology (2024)

MPZ exhibited a high 5-year retention rate, particularly in patients requiring IS. This study implies that long-term use of MPZ may mitigate irreversible organ damage.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
prognostic factors
peritoneal dialysis
genome wide
emergency department
randomized controlled trial
gene expression
cross sectional
single cell
double blind